HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.

Abstract
Mantle cell lymphoma (MCL) is characterized by the t(11;14) and cyclin D1 overexpression. However, additional molecular events are most likely required for oncogenesis, possibly through cell cycle and apoptosis deregulation. We hypothesized that mammalian target of rapamycin (mTOR) is activated in MCL and contributes to tumor proliferation and survival. In MCL cell lines, pharmacological inhibition of the phosphoinositide 3-kinase/AKT pathway was associated with decreased phosphorylation (activation) of mTOR and its downstream targets phosphorylated (p)-4E-BP1, p-p70S6 kinase, and p-ribosomal protein S6, resulting in apoptosis and cell cycle arrest. These changes were associated with down-regulation of cyclin D1 and the anti-apoptotic proteins cFLIP, BCL-XL, and MCL-1. Furthermore, silencing of mTOR expression using mTOR-specific short interfering RNA decreased phosphorylation of mTOR signaling proteins and induced cell cycle arrest and apoptosis. Silencing of eukaryotic initiation factor (eIF4E), a downstream effector of mTOR, recapitulated these results. We also assessed mTOR signaling in MCL tumors using immunohistochemical methods and a tissue microarray: 10 of 30 (33%) expressed Ser473p-AKT, 13 of 21 (62%) Ser2448p-mTOR, 22 of 22 (100%) p-p70S6K, and 5 of 20 (25%) p-ribosomal protein S6. Total eIF4E binding protein 1 and eukaryotic initiation factor 4E were expressed in 13 of 14 (93%) and 16 of 29 (55%) MCL tumors, respectively. These findings suggest that the mTOR signaling pathway is activated and may contribute to cell cycle progression and tumor cell survival in MCL.
AuthorsEvangelia Peponi, Elias Drakos, Guadalupe Reyes, Vasiliki Leventaki, George Z Rassidakis, L Jeffrey Medeiros
JournalThe American journal of pathology (Am J Pathol) Vol. 169 Issue 6 Pg. 2171-80 (Dec 2006) ISSN: 0002-9440 [Print] United States
PMID17148679 (Publication Type: Journal Article)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Cell Cycle Proteins
  • EIF4EBP1 protein, human
  • Eukaryotic Initiation Factor-4E
  • Phosphoproteins
  • Protein Kinases
  • MTOR protein, human
  • Proto-Oncogene Proteins c-akt
  • Ribosomal Protein S6 Kinases, 70-kDa
  • Ribosomal Protein S6 Kinases, 90-kDa
  • TOR Serine-Threonine Kinases
Topics
  • Adaptor Proteins, Signal Transducing (metabolism)
  • Apoptosis
  • Cell Cycle
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Down-Regulation
  • Eukaryotic Initiation Factor-4E (physiology)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lymphoma, Mantle-Cell (genetics, metabolism, pathology)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphoproteins (metabolism)
  • Phosphorylation
  • Protein Kinases (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Ribosomal Protein S6 Kinases, 70-kDa (metabolism)
  • Ribosomal Protein S6 Kinases, 90-kDa (metabolism)
  • Signal Transduction
  • TOR Serine-Threonine Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: